Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Torguson

Showing results (1-10 of 378) with videos related to

Pageof 38
Sort By:
The American Journal of Cardiology|December 10, 2008
Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on the Xience V Everolimus-Eluting Coronary StentRebecca Torguson, Ron Waksman
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 18, 2012
Overview of the 2011 food and drug administration's circulatory system devices panel of the medical devices advisory committee meeting on the Zilver® PTX® drug-eluting peripheral stentDanny Dvir, Rebecca Torguson, Ron Waksman
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 24, 2021
Overview of the virtual 2020 FDA's circulatory system devices advisory panel on Neovasc reducer systemGiorgio A Medranda, Rebecca Torguson, Ron Waksman
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 17, 2016
The AngelMed Guardian system: Is there a role for implantable devices for early detection of coronary artery occlusion?Toby Rogers, Arie Steinvil, Rebecca Torguson, et al.
JACC. Cardiovascular Interventions|September 10, 2016
Overview of the 2016 U.S. Food and Drug Administration Circulatory System Devices Advisory Panel Meeting on the Absorb Bioresorbable Vascular Scaffold SystemArie Steinvil, Toby Rogers, Rebecca Torguson, et al.
American Heart Journal|September 11, 2013
Overview of the 2012 Food and Drug Administration circulatory system devices panel meeting on the reclassification of external counterpulsation, intra-aortic balloon pump, and non-roller-type cardiopulmonary bypass blood pump devicesSa'ar Minha, Omid Fatemi, Rebecca Torguson, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 11, 2021
Overview of the Virtual 2021 FDA's Circulatory System Devices Advisory Panel on Lutonix 014 Drug-Coated Percutaneous Transluminal Angioplasty Catheter for Below-the-Knee Lesions in Critical Limb IschemiaBrian C Case, Rebecca Torguson, Cheng Zhang, et al.
American Heart Journal|June 20, 2017
Feasibility of transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis: Rationale and design of the Low Risk TAVR (LRT) studyToby Rogers, Rebecca Torguson, Roshni Bastian, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 17, 2017
A comparison of cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention: A network meta-analysisPeter C Westman, Michael J Lipinski, Rebecca Torguson, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 19, 2019
Overview of the 2018 US Food and Drug Administration Circulatory System Devices Panel meeting on the INCRAFT AAA Stent Graft SystemMicaela Iantorno, Kyle D Buchanan, Nelson L Bernardo, et al.
Pageof 38

Showing results (1-10 of 378) with videos related to

Sort By:
Pageof 38
The American Journal of Cardiology|December 10, 2008
Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on the Xience V Everolimus-Eluting Coronary StentRebecca Torguson, Ron Waksman
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 18, 2012
Overview of the 2011 food and drug administration's circulatory system devices panel of the medical devices advisory committee meeting on the Zilver® PTX® drug-eluting peripheral stentDanny Dvir, Rebecca Torguson, Ron Waksman
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 24, 2021
Overview of the virtual 2020 FDA's circulatory system devices advisory panel on Neovasc reducer systemGiorgio A Medranda, Rebecca Torguson, Ron Waksman
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 17, 2016
The AngelMed Guardian system: Is there a role for implantable devices for early detection of coronary artery occlusion?Toby Rogers, Arie Steinvil, Rebecca Torguson, et al.
JACC. Cardiovascular Interventions|September 10, 2016
Overview of the 2016 U.S. Food and Drug Administration Circulatory System Devices Advisory Panel Meeting on the Absorb Bioresorbable Vascular Scaffold SystemArie Steinvil, Toby Rogers, Rebecca Torguson, et al.
American Heart Journal|September 11, 2013
Overview of the 2012 Food and Drug Administration circulatory system devices panel meeting on the reclassification of external counterpulsation, intra-aortic balloon pump, and non-roller-type cardiopulmonary bypass blood pump devicesSa'ar Minha, Omid Fatemi, Rebecca Torguson, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 11, 2021
Overview of the Virtual 2021 FDA's Circulatory System Devices Advisory Panel on Lutonix 014 Drug-Coated Percutaneous Transluminal Angioplasty Catheter for Below-the-Knee Lesions in Critical Limb IschemiaBrian C Case, Rebecca Torguson, Cheng Zhang, et al.
American Heart Journal|June 20, 2017
Feasibility of transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis: Rationale and design of the Low Risk TAVR (LRT) studyToby Rogers, Rebecca Torguson, Roshni Bastian, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 17, 2017
A comparison of cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention: A network meta-analysisPeter C Westman, Michael J Lipinski, Rebecca Torguson, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 19, 2019
Overview of the 2018 US Food and Drug Administration Circulatory System Devices Panel meeting on the INCRAFT AAA Stent Graft SystemMicaela Iantorno, Kyle D Buchanan, Nelson L Bernardo, et al.
Pageof 38